| Financial Year |
March 31 2023 |
| Monetary Funds |
122,911,827.02 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
122,817,694.70 |
| Accounts Receivable |
1,300,538,188.80 |
| Advances to Suppliers |
29,857,215.87 |
| Other Receivables |
47,822,613.19 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
373,816,740.04 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
2,257,367.09 |
| Total Current Assets |
2,055,128,252.97 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
288,635,644.72 |
| Under-construction Projects |
25,910,503.44 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
88,358,556.92 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
2,990,819.71 |
| Deferred Income Tax Assets |
63,249,987.00 |
| Other Non-Current Assets |
2,172,270.97 |
| Sub-Total of Non-Current Assets |
478,253,830.28 |
| Total Assets |
2,533,382,083.25 |
| Short-Term Loans |
1,058,729,321.47 |
| Trading Financial liabilities |
-- |
| Notes Payable |
41,315,253.00 |
| Accounts Payable |
143,682,367.53 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
18,356,251.48 |
| Taxes Payable |
2,502,232.92 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
136,075,279.09 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,374,527.35 |
| Other Current Liabilities |
9,020,282.02 |
| Sub-Total of Current Liabilities |
1,459,875,436.35 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
15,078,760.12 |
| Deferred Income Tax Liabilities |
1,809,548.40 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
18,885,539.00 |
| Total Liabilities |
1,478,760,975.35 |
| Paid-In Capital(Or Share Stock) |
718,146,000.00 |
| Capital Surplus |
149,794,234.06 |
| Surplus Reserve |
92,362,571.74 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
112,643,080.39 |
| Minority Stockholder's Interest |
-18,324,778.29 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,072,945,886.19 |
| Owner's Equity（Stockholder's Equity） |
1,054,621,107.90 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,533,382,083.25 |
